Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Erhan Ararat to Breast Neoplasms

This is a "connection" page, showing publications Erhan Ararat has written about Breast Neoplasms.

 
Connection Strength
  
 
 
1.122
  
  1. Ararat E, Sahin I, Arslan C, Aksoy S, Dizdar O, Ozisik Y, Altundag K. Clinical and pathological characteristics of very young breast cancer patients (= 25 years of age). J BUON. 2011 Apr-Jun; 16(2):372.
    View in: PubMed
    Score: 0.199
  2. Ararat E, Sahin I, Altundag K. How addition of capecitabine might be more beneficial in the neoadjuvant treatment of breast cancer. J BUON. 2011 Apr-Jun; 16(2):377.
    View in: PubMed
    Score: 0.199
  3. Ararat E, Sahin I, Altundag K. Mechanisms behind the aspirin use and decreased breast cancer incidence. J BUON. 2011 Jan-Mar; 16(1):180.
    View in: PubMed
    Score: 0.196
  4. Ararat E, Sahin I, Altundag K. Aspirin intake may prevent metastasis in patients with triple-negative breast cancer. Med Oncol. 2011 Dec; 28(4):1308-10.
    View in: PubMed
    Score: 0.190
  5. Sahin I, Ararat E, Sever AR, Altundag K. Early start of adjuvant chemotherapy in breast cancer. J BUON. 2015 Jul-Aug; 20(4):1169.
    View in: PubMed
    Score: 0.067
  6. Koca E, Kuzan TY, Dizdar O, Babacan T, Sahin I, Ararat E, Altundag K. Outcomes of locally advanced breast cancer patients with = 10 positive axillary lymph nodes. Med Oncol. 2013; 30(3):615.
    View in: PubMed
    Score: 0.058
  7. Tosur M, Sahin I, Ararat E, Babacan T, Altundag K. Clinical and pathological characteristics of patients 80 years and older with breast cancer. J BUON. 2012 Apr-Jun; 17(2):397-8.
    View in: PubMed
    Score: 0.053
  8. Sahin I, Ararat E, Hashimov A, Altundag K. Sequential taxane and anthracycline-containing neo-adjuvant regimens; any rationale behind the sequence? Breast. 2011 Jun; 20(3):291.
    View in: PubMed
    Score: 0.050
  9. Sahin I, Ararat E, Altundag K. BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes? J BUON. 2011 Jan-Mar; 16(1):184-5.
    View in: PubMed
    Score: 0.049
  10. Sahin I, Ararat E, Altundag K. Possible mechanisms behind taxane-anthracycline sequencing. Lancet Oncol. 2010 Jun; 11(6):514-5.
    View in: PubMed
    Score: 0.047
  11. Sahin I, Ararat E, Altundag K. How can Nolvadex abolish arthralgia in women taking newer generic Tamoxifen preparations? Breast. 2010 Oct; 19(5):436.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.